A peek behind the paper – Oliver Lieleg on building nanoparticle drug carriers unlocked by specific DNA ‘keys’

Refer a colleague
In this interview, Oliver Lieleg, Professor of Biomechanics at the Technical University of Munich (Germany), discusses recent research from his lab where they developed mucin-based nanoparticle drug carriers that only release their therapeutic load when triggered by specific DNA ‘keys’ inside of target cells. Read the full research article here >>> Please can you introduce yourself and give a short summary of your research career to date? I am a physicist by training, with a specialization in molecular and cellular biophysics; this is also the area in which I conducted my PhD research, studying the relationship between microarchitecture and viscoelastic...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for free.